@article{CHEN2022, 
author = {Wenlin CHEN and Yaning WANG and Hao XING and Tingyu LIANG and Yixin SHI and Hai WANG and Huiyu YANG and Qianshu LIU and Junlin LI and Xiaopeng GUO and Yu WANG and Wenbin MA},
title = {Annual Research Progress of Glioma in China in 2021},
year = {2022},
journal = {Medical Journal of Peking Union Medical College Hospital},
volume = {13},
number = {5},
pages = {760-767},
keywords = {glioma, magnetic resonance imaging, temozolomide, targeted therapy, immune microenvironment},
url = {https://www.sciopen.com/article/10.12290/xhyxzz.2022-0235},
doi = {10.12290/xhyxzz.2022-0235},
abstract = {Glioma, the most prevalent primary malignant tumor of the central nervous system, has a high degree of malignancy and poor prognosis for patients. At present, the researches of glioma mainly focus on the investigation of the mechanism of tumor occurrence and the discovery of new therapeutic methods and agents. In-depth researches have also been conducted on the optimization of molecular pathological typing of glioma, improvement of diagnostic imaging techniques and formulation of comprehensive treatment guidelines. In this review, we summarize the achievements and important progress made by Chinese medical scientists in the field of glioma in 2021, and propose possible future research directions with the aim of providing reference for clinical research.}
}